2025 | High-dose rifampicin for 3 months after culture conversion for drug-susceptible pulmonary tuberculosis
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2025 | Comparison of Patients Who Were Not Evaluated and Lost to Follow-Up with Multidrug/Rifampin-Resistant Tuberculosis in South Korea
| YONSEI MEDICAL JOURNAL |
2025 | Diagnosis and Treatment of latent tuberculosis infection in adults in South Korea
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2024 | Malnutrition is associated with mortality in Sjögren's syndrome-associated interstitial lung disease
| SCIENTIFIC REPORTS |
2024 | Development and Validation of Deep Learning-Based Infectivity Prediction in Pulmonary Tuberculosis Through Chest Radiography: Retrospective Study
| JOURNAL OF MEDICAL INTERNET RESEARCH |
2024 | Effect of comorbidities on mortality in patients with nontuberculous mycobacterial infection in Korea: National Health Insurance Service-National Sample Cohort data | SCIENTIFIC REPORTS |
2024 | Homelessness and mortality: gender, age, and housing status inequity in Korea
| EPIDEMIOLOGY AND HEALTH |
2024 | Medical Costs of Nontuberculous Mycobacterial Pulmonary Disease, South Korea, 2015-2019
| EMERGING INFECTIOUS DISEASES |
2024 | PARK2 as a susceptibility factor for nontuberculous mycobacterial pulmonary disease
| RESPIRATORY RESEARCH |
2024 | Predicting Successful Weaning through Sonographic Measurement of the Rapid Shallow Breathing Index
| JOURNAL OF CLINICAL MEDICINE |
2024 | Association of physical inactivity and handgrip strength with non-tuberculous mycobacterial pulmonary disease | INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE |
2024 | Epidemiological Characteristics of Nontuberculous Mycobacterial Pulmonary Disease in South Korea: A Meta-analysis of Individual Participant Data
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2024 | Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2024 | Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort | CLINICAL INFECTIOUS DISEASES |
2024 | Usefulness of the mini nutritional assessment short-form for evaluating nutritional status in patients with nontuberculous mycobacterial pulmonary disease: a prospective cross-sectional study
| BMC INFECTIOUS DISEASES |
2024 | Artificial intelligence-based radiographic extent analysis to predict tuberculosis treatment outcomes: a multicenter cohort study
| SCIENTIFIC REPORTS |
2024 | Predictors of positive tuberculin skin test in neonates exposed to pulmonary tuberculosis
| PLOS ONE |
2024 | Beyond reducing direct medical cost: examining health outcomes in tuberculosis through a difference-in-differences analysis of South Korea's out-of-pocket payment exception policy
| FRONTIERS IN PUBLIC HEALTH |
2024 | Clinical Characteristics and Treatment Outcomes of Pulmonary Diseases Caused by Coinfections With Multiple Nontuberculous Mycobacterial Species
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2024 | Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study
| THORACIC CANCER |
2024 | Differences of respiratory mechanics in mechanical ventilation of acute respiratory distress syndrome between patients with COVID-19 and Influenza A | RESPIRATORY RESEARCH |
2024 | Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2024 | Diagnosis of Primary Ciliary Dyskinesia via Whole Exome Sequencing and Histologic Findings
| YONSEI MEDICAL JOURNAL |
2024 | A Quasi-experimental Study on the Effect of Pre-entry Tuberculosis Screening for Immigrants on Treatment Outcomes in South Korea: A Difference-in-Differences Analysis
| JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH |
2024 | Risk Factors for Unfavorable Outcomes of Tuberculosis in Korea: Implications for Patient-Centered Care in Tuberculosis Treatment
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2024 | Low household income increases the risk of tuberculosis recurrence: a retrospective nationwide cohort study in South Korea
| PUBLIC HEALTH |
2023 | Association between diabetes mellitus and cause of death in patients with tuberculosis: A Korean nationwide cohort study
| PLOS ONE |
2023 | Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease
| ANNALS OF MEDICINE |
2023 | Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2023 | Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data
| BMJ OPEN RESPIRATORY RESEARCH |
2023 | Disseminated Nontuberculous Mycobacterial Infection in a Tertiary Referral Hospital in South Korea: A Retrospective Observational Study
| YONSEI MEDICAL JOURNAL |
2023 | Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis
| ERJ OPEN RESEARCH |
2023 | Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease
| SCIENTIFIC REPORTS |
2023 | Incidence and associated risk factors of nontuberculous mycobacterial infection in patients with depression
| PLOS ONE |
2023 | Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score Matching
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2023 | Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2023 | Cost-Effectiveness of Age-Expanding Strategy of Latent Tuberculosis Infection Treatment in Household Contacts in South Korea
| YONSEI MEDICAL JOURNAL |
2023 | Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
| INFECTIOUS DISEASES AND THERAPY |
2023 | Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer | FRONTIERS IN ONCOLOGY |
2023 | Prevalence and associated factors of diabetes mellitus among patients with tuberculosis in South Korea from 2011 to 2018: a nationwide cohort study
| BMJ OPEN |
2023 | Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST)
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2023 | Healthcare use and medical cost before and after diagnosis of nontuberculous mycobacterial infection in Korea: the National Health Insurance Service-National Sample Cohort Study
| THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE |
2023 | Multicenter Testing of a Simple Molecular Diagnostic System for the Diagnosis of Mycobacterium Tuberculosis
| BIOSENSORS |
2023 | Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: a retrospective national cohort study
| INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
2023 | Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection
| DIAGNOSTICS |
2023 | Gender differences in tuberculosis patients with comorbidity: A cross-sectional study using national surveillance data and national health insurance claims data in South Korea
| PLOS ONE |
2023 | Clinical Outcomes and Prognosis of Patients with Interstitial Lung Disease Undergoing Lung Cancer Surgery: A Propensity Score Matching Study | CLINICAL LUNG CANCER |
2022 | A low risk of nosocomial transmission of subclinical tuberculosis to neonates in a postpartum care center under COVID-19 control measures
| Osong Public Health and Research Perspectives |
2022 | 9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea | LANCET |
2022 | Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation | JOURNAL OF INFECTION AND CHEMOTHERAPY |